Medical Center- University of Freiburg
Freiburg im Breisgau, CA, 79106, Germany
NCT Number: NCT05988047
In this study, we aim to investigate the expression of CKLF like MARVEL transmembrane domain containing 6 (CMTM6) in leukemia cells of patients with acute myeloid leukemia (AML). We will use peripheral blood samples and assess CMTM6 expression by flow cytometry and Western Blot.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Freiburg im Breisgau, CA, 79106, Germany
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At primary diagnosis
CMTM6 expression on blasts/monocytes will be measured by flow cytometry
Time frame: At primary diagnosis
T cell activation and cytokine production will be measured by flow cytometry
Time frame: At primary diagnosis
CMTM6 expression on blasts/monocytes will be measured by Western blot
University of Freiburg
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05906914
Acute Myeloid Leukemia, Adult, Hematologic Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT03902665
Acute Myeloid Leukemia, Adult, Hematologic Diseases
Roma, RM, Italy
View Trial DetailsNCT04050280
Acute Myeloid Leukemia Recurrent, Acute Myeloid Leukemia, Adult
Baltimore, Maryland, United States
View Trial DetailsNCT05133882
Acute Myeloid Leukemia, Adult, Hematologic Diseases
Hanzhou, Zhejiang, China
View Trial Details